ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development and validation of an ensemble machine-learning model for predicting early mortality among patients with bone metastases of hepatocellular carcinoma

Long, Ze; Yi, Min; Qin, Yong*; Ye, Qianwen*; Che, Xiaotong; Wang, Shengjie*; Lei, Mingxing上海交通大学; 哈尔滨医科大学; 河北医科大学; 中国医学科学院; 中国医学科学院北京协和医院; 6; y
Frontiers in Oncology2023-2-20DOI: 10.3389/fonc.2023.1144039
1被引4阅读
引用收藏
分享

摘要

PurposeUsing an ensemble machine learning technique that incorporates the results of multiple machine learning algorithms, the study's objective is to build a reliable model to predict the early mortality among hepatocellular carcinoma (HCC) patients with bone metastases. MethodsWe extracted a cohort of 124,770 patients with a diagnosis of hepatocellular carcinoma from the Surveillance, Epidemiology, and End Results (SEER) program and enrolled a cohort of 1897 patients who were diagnosed as having bone metastases. Patients with a survival time of 3 months or less were considered to have had early death. To compare patients with and without early mortality, subgroup analysis was used. Patients were randomly divided into two groups: a training cohort (n = 1509, 80%) and an internal testing cohort (n = 388, 20%). In the training cohort, five machine learning techniques were employed to train and optimize models for predicting early mortality, and an ensemble machine learning technique was used to generate risk probability in a way of soft voting, and it was able to combine the results from the multiply machine learning algorithms. The study employed both internal and external validations, and the key performance indicators included the area under the receiver operating characteristic curve (AUROC), Brier score, and calibration curve. Patients from two tertiary hospitals were chosen as the external testing cohorts (n = 98). Feature importance and reclassification were both operated in the study. ResultsThe early mortality was 55.5% (1052/1897). Eleven clinical characteristics were included as input features of machine learning models: sex (p = 0.019), marital status (p = 0.004), tumor stage (p = 0.025), node stage (p = 0.001), fibrosis score (p = 0.040), AFP level (p = 0.032), tumor size (p = 0.001), lung metastases (p < 0.001), cancer-directed surgery (p < 0.001), radiation (p < 0.001), and chemotherapy (p < 0.001). Application of the ensemble model in the internal testing population yielded an AUROC of 0.779 (95% confidence interval [CI]: 0.727-0.820), which was the largest AUROC among all models. Additionally, the ensemble model (0.191) outperformed the other five machine learning models in terms of Brier score. In terms of decision curves, the ensemble model also showed favorable clinical usefulness. External validation showed similar results; with an AUROC of 0.764 and Brier score of 0.195, the prediction performance was further improved after revision of the model. Feature importance demonstrated that the top three most crucial features were chemotherapy, radiation, and lung metastases based on the ensemble model. Reclassification of patients revealed a substantial difference in the two risk groups' actual probabilities of early mortality (74.38% vs. 31.35%, p < 0.001). Patients in the high-risk group had significantly shorter survival time than patients in the low-risk group (p < 0.001), according to the Kaplan-Meier survival curve. ConclusionsThe ensemble machine learning model exhibits promising prediction performance for early mortality among HCC patients with bone metastases. With the aid of routinely accessible clinical characteristics, this model can be a trustworthy prognostic tool to predict the early death of those patients and facilitate clinical decision-making.

学科与关键词

关键词
bone metastasesmachine learningensemble modelearly mortalityhepatocellular carcinoma
相关
加载中…
  • Short-term prognosis for hepatocellular carcinoma patients with lung metastasis: A retrospective cohort study based on the SEER database
    Chen, Shicheng; Li, Xiaowen; Liang, Yichao; Lu, Xinyu; Huang, Yingyi; Zhu, Jiajia; Li, Jun*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2022, 101(45): e31399.被引 1
  • Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients
    Cui, Yunpeng; Shi, Xuedong*; Wang, Shengjie; Qin, Yong*; Wang, Bailin; Che, Xiaotong; Lei, Mingxing*Frontiers in Public Health, 2022, 10: 1019168.被引 8
  • A Web-Based Calculator to Predict Early Death Among Patients With Bone Metastasis Using Machine Learning Techniques: Development and Validation Study
    Lei, Mingxing; Wu, Bing; Zhang, Zhicheng; Qin, Yong; Cao, Xuyong; Cao, Yuncen; Liu, Baoge; Su, Xiuyun; Liu, Yaosheng*JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25: e47590.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-02-20
卷期
第 13 卷
页码
1144039
DOI
10.3389/fonc.2023.1144039
成果收录
SCIE
资助标注
National Orthopedics and Sports Rehabilitation Clinical Medical Research Center Innovation Fund Project [2021-NCRC-CXJJ-PY-20]

作者

  • L

    Long, Ze (第一作者)

    2

  • Y

    Yi, Min

    chinese acad med sci · inst med · peking union med coll

查看全部 7 位作者收起作者
  • Q

    Qin, Yong (通讯)

    2 · harbin med univ

  • Y

    Ye, Qianwen (通讯)

  • C

    Che, Xiaotong

  • W

    Wang, Shengjie (通讯)

    6 · shanghai jiao tong univ

  • L

    Lei, Mingxing

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417